# Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina

> **NCT01425359** · PHASE4 · COMPLETED · sponsor: **Gilead Sciences** · enrollment: 949 (actual)

## Conditions studied

- Angina Pectoris
- Coronary Artery Disease
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** Ranolazine
- **DRUG:** Ranolazine placebo

## Key facts

- **NCT ID:** NCT01425359
- **Lead sponsor:** Gilead Sciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 949 (ACTUAL)
- **Last updated:** 2014-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01425359

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01425359, "Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01425359. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*